All Stories

  1. Antibody therapy against EGFR, HER2 and HER3 for the treatment of Osimertinib-resistant NSCLC

    Article • EMBO Molecular Medicine, December 2017, EMBO

    Dominick Burton, Maicol Mancini

  2. Cell surface proteins help immune cells to recognize and kill senescent cells

    Article • Aging, February 2016, Impact Journals, LLC

    Dr Bojan Polic, Dominick Burton